Low Sperm Motility (Asthenozoospermia): Causes, Treatment & Supplements
Poor sperm motility is the most common semen abnormality in infertile men — and the one most directly addressable through targeted supplementation.
Sperm motility refers to the ability of sperm to move efficiently through the female reproductive tract to reach and fertilise an egg. The World Health Organization defines normal progressive motility as ≥32% of sperm showing forward progressive movement (grade A + B). Below this threshold — a condition called asthenozoospermia — fertilisation rates drop significantly, even when sperm count and morphology are normal. Progressive motility is entirely dependent on ATP production in sperm mitochondria, which is why nutrients targeting mitochondrial function have the strongest evidence base for this specific parameter.
32%
WHO minimum for normal progressive motility
19–20%
Prevalence in infertile men
12–16 wks
Time to measurable improvement on supplements
What It Means
Low motility means a higher proportion of your sperm either move sluggishly in place (non-progressive) or do not move at all (immotile). On semen analysis, this shows as reduced total progressive motility (% of all sperm that swim forward). Mild asthenozoospermia: 20–31% progressive. Moderate: 10–19%. Severe: below 10%. Natural conception requires sperm to travel through cervical mucus, up the uterus, and into the fallopian tube — only sperm with strong forward motility can complete this journey reliably.
How It's Diagnosed
Standard semen analysis (SA) measures motility as part of a WHO-criteria assessment. At least 2 SAs performed 2–4 weeks apart are recommended for diagnosis, as motility has high within-individual variability. The test measures: % progressively motile (grade A: rapid linear, grade B: slow/curved), % non-progressively motile, and % immotile. Total motile sperm count (TMSC) = concentration × volume × % motile — this combined metric is more predictive of fertility outcomes than any individual parameter.
How Common Is It
Asthenozoospermia is present in approximately 19–20% of infertile men, making it the single most common semen abnormality. It frequently co-occurs with oligozoospermia (low count) and teratozoospermia (poor morphology) in a pattern called OAT syndrome. Isolated asthenozoospermia with normal count and morphology is less common but highly treatable with targeted supplementation.
Supplement Support — Evidence-Based
These ingredients have clinical evidence for supporting this condition specifically.
CoQ10 (Ubiquinol)
Directly fuels sperm mitochondria. The most evidence-backed single supplement for asthenozoospermia. Multiple RCTs show significant progressive motility improvements at 200–300mg/day over 12–26 weeks.
L-Carnitine
Powers sperm maturation in the epididymis and fatty acid delivery to mitochondria. Concentrated 2,000× higher in the epididymis than blood. RCTs show significant motility gains at 2g/day.
Selenium
Structurally integrated into sperm flagella via snGPX4. Deficiency produces bent-tail morphology. Serum selenium correlates directly with progressive motility in multiple population studies.
The Mitochondrial Energy Failure Model
Forward progressive motility is powered by ATP generated in the sperm midpiece — a ring of mitochondria wrapped around the flagellar axoneme. Each sperm beat requires synchronised cross-bridge cycling in dynein ATPase motor proteins. This requires a continuous, high-flux ATP supply from mitochondrial oxidative phosphorylation. When mitochondria underperform — due to CoQ10 deficiency, carnitine deficiency, oxidative damage to the inner membrane, or structural defects from selenium deficiency — ATP output drops, flagellar beat frequency and amplitude decrease, and the sperm slows or stops. This is the primary mechanism in most cases of idiopathic asthenozoospermia.
Varicocele and Motility
Varicocele (dilated veins in the scrotum) is found in 15–20% of all men and 40% of infertile men. Elevated scrotal temperature from venous pooling increases reactive oxygen species (ROS) production in the testis and epididymis. This oxidative stress attacks sperm mitochondria, progressively impairing motility as sperm mature. Men with varicocele who are not surgical candidates can use antioxidant supplementation (CoQ10, selenium, vitamin C, vitamin E) to partially offset the oxidative burden. However, surgical repair (varicocelectomy) remains the most effective intervention for varicocele-related motility impairment.
How Long to Improve Motility with Supplements
Spermatogenesis takes ~64 days from stem cell to mature sperm. Supplementation started today will not affect today's sperm — only sperm currently being produced. This is why 12–16 weeks of consistent supplementation is the minimum before repeating semen analysis. The 60-day supply minimum at ApexFertility is calibrated to cover one full spermatogenesis cycle. Multiple semen analyses are recommended: one at baseline before starting, one at 8 weeks (to confirm response), and one at 16 weeks (for the full assessment).
Related Guides
Recommended Protocol
The Recovery Stack — Formulated for Motility
CoQ10 (200mg ubiquinol), L-Carnitine (2,000mg), and Selenium (200mcg selenomethionine) at clinical doses — the three compounds with the strongest evidence for asthenozoospermia, combined with full-spectrum antioxidant support.
60-day guarantee · Free shipping
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. Consult your healthcare provider before starting any new supplement regimen.